Tatva Chintan Pharma opened higher at ₹1,875.00, compared with its previous close of ₹1,871.10. During today's session, the stock has traded between ₹1,782.10 and ₹1,875.00, with an average traded price of ₹1,811.32. It is currently showing a downward intraday trend.
An investment of ₹10,000 made 5 years ago in Tatva Chintan Pharma is now worth
₹ 7,843.00
resulting in a loss of
₹ 2,157.00 (21.57%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
-29.80 (-1.59%)
Day High
₹1,875.00
Day Low
₹1,782.10
Day Open
₹1,875.00
Prev Close
₹1,871.10
Volume
64,375
Value Traded
₹11.66 Cr
1W Return
2.35%
1M Return
14.46%
3M Return
38.81%
6M Return
53.16%
1Y Return
72.21%
Market Cap (₹ Cr.)
4,307
PE Ratio
85.10
PB Ratio
5.59
Dividend Yield
0.11%
ROE
5.38%
ROCE
7.57%
Book Value (₹)
334.20
Face Value (₹)
10.00
EPS (TTM)
6.83
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
2.35%
6 Week
-
1 Month
14.46%
3 Month
38.81%
9 Month
43.04%
Tatva Chintan AGM approves all 10 resolutions including director re-appointments
All 10 resolutions proposed at the 30th AGM were passed with requisite majority. Re-appointment of MD Chintan Nitinkumar Shah and two WTDs approved for three years. Borrowing limits increased and charges on assets created under Companies Act provisions. Audited financial statements for FY26 and dividend declaration approved by shareholders.
17 days agoTatva Chintan Pharma Chem schedules investor meetings on September 23
Tatva Chintan Pharma Chem plans virtual investor meetings on September 23, 2026. Interactions include Ask Investment Managers Limited and other analysts. Disclosures made under SEBI LODR Regulation 30 to BSE and NSE. Discussions limited to publicly available information only.
26 days agoTatva Chintan Pharma schedules analyst and investor meet on September 15
Tatva Chintan Pharma has planned a meeting with analysts and investors on September 15. The announcement signals the company's engagement with the investment community.
1mo agoTatva Chintan Pharma fixes Sep 11 record date for FY26 dividend
Record date for FY26 final dividend of ₹2 per share is September 11, 2026. Book closure period runs from September 12 to September 25, 2026. E-voting cut-off date is set for September 18, 2026. 30th AGM scheduled for September 25, 2026 via video conference. Company reported FY26 PAT of ₹390.82 million on revenue of ₹4,962.96 million.
1mo agoTatva Chintan Pharma Chem files FY26 BRSR; turnover at ₹4,962.96 million
Tatva Chintan Pharma Chem reported a standalone turnover of ₹4,962.96 million for FY26. Exports account for 75% of the company's total revenue. Total energy consumption from non-renewable sources rose to 285,897.23 Gigajoules. The workforce comprises 363 permanent employees and 734 workers. No regulatory fines or penalties were recorded during the fiscal year.
1mo agoTatva Chintan Pharma accepts Ajay Rawat resignation as R&D head
Tatva Chintan Pharma Chem Ltd announced the acceptance of Mr. Ajay Rawat’s resignation as Assistant Vice President – Research and Development. Effective November 13, 2026, Mr. Rawat will cease to be part of the senior management team after submitting his resignation on August 14, 2026. The move was disclosed under Regulation 30 of SEBI Listing Regulations.
1mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,497.60 | +1.35% | ₹1,52,437.66 | 56.20 | -0.86% | |
| ₹2,492.00 | +0.14% | ₹73,869.07 | 33.91 | -17.61% | |
| ₹4,550.80 | -1.16% | ₹49,990.54 | 84.18 | +22.07% | |
| ₹8,468.00 | -1.09% | ₹43,434.38 | 55.68 | +78.61% | |
| ₹660.00 | -0.21% | ₹33,301.90 | 41.50 | +44.90% | |
| ₹1,715.70 | -3.57% | ₹22,772.12 | 100.43 | +128.70% | |
| ₹1,622.10 | +0.23% | ₹22,124.32 | 28.16 | -9.34% | |
| ₹487.80 | +2.93% | ₹17,687.36 | 32.37 | +29.05% | |
| ₹5,998.00 | +0.33% | ₹17,659.16 | 21.69 | -0.56% | |
| ₹5,422.50 | -1.44% | ₹16,625.37 | 38.52 | +16.41% | |
| ₹3,421.20 | +1.27% | ₹14,808.88 | 22.73 | -25.49% | |
| ₹1,165.00 | +1.16% | ₹13,263.51 | 58.35 | -8.09% |
An investment of ₹10,000 made 5 years ago in Tatva Chintan Pharma is now worth
₹ 7,843.00
resulting in a loss of
₹ 2,157.00 (21.57%)
Note: Past profits do not guarantee future returns.
